Ebos to continue acquisition spree as profits rise
Ebos chief executive brushes off Australian market changes.
Hot Topic
Rich List
Ebos [NZX:EBO] says the diversification of its business has helped weather changes in the Australian drug markets as the healthcare group continues to shop around for new acquisitions.
The company today posted a first-half profit increase of 12% to $76.7 million and said the
Want to read more? It's easy.
Choose your subscription
Already have an account? Login
Smartphone Only Subscription
NZ$29.95 / monthly
Monthly Premium Online Subscription
NZ$49.95 / monthly
Smartphone Only Annual Subscription
NZ$299.00 / yearly
Yearly Premium Online Subscription
NZ$499.00 / yearly
Premium Group Membership 10 Users
NZ$385+GST / monthly
$38.5 per user - Pay by monthly credit card debitPremium Group Membership 20 Users
NZ$660+GST / monthly
$33 per user - Pay by monthly credit card debitPremium Group Membership 50 Users
NZ$1375+GST / monthly
$27.5 per user - Pay by monthly credit card debitPremium Group Membership 100 Users
NZ$2100+GST / monthly
$21 per user - Pay by monthly credit card debitYearly Premium Online Subscription + NBR Marketplace
NZ$999.00 / yearly
Individual
Group membership
NBR Marketplace
Victoria Young
Wed, 21 Feb 2018
Wed, 21 Feb 2018
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
Ebos to continue acquisition spree as profits rise
73489